CORBUS PHARMACEUTICALS

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 11 2024 06:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 11 2024 06:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 10 2024 07:00:01 提供 Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit

26 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference

05 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

20 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

06 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 7 2024 09:44:31 提供 NetDania Notify

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

30 7 2024 07:50:40 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

16 7 2024 08:55:39 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

15 7 2024 09:01:36 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 7 2024 09:50:10 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 6 2024 08:45:05 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 6 2024 15:10:04 提供 NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 6 2024 09:16:45 提供 NetDania Notify

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024

01 6 2024 09:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

30 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

23 5 2024 16:05:26 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 5 2024 09:10:19 提供 NetDania Notify